Renaissance Technologies - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 39 filers reported holding PYXIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$430
-33.6%
216,251
-14.6%
0.00%0.0%
Q2 2023$648
+71.4%
253,229
+168.8%
0.00%0.0%
Q1 2023$378
+237.5%
94,200
+12.7%
0.00%
Q4 2022$112
-100.0%
83,600
-35.1%
0.00%
Q3 2022$254,000
+41.9%
128,802
+70.9%
0.00%
Q2 2022$179,00075,3710.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 645,149$1,535,0000.86%
TANG CAPITAL MANAGEMENT LLC 1,379,080$3,282,0000.50%
Newtyn Management, LLC 800,000$1,904,0000.36%
BVF INC/IL 2,938,851$6,994,0000.34%
Cormorant Asset Management, LP 668,854$1,592,0000.12%
Laurion Capital Management LP 3,170,803$7,547,0000.12%
Perceptive Advisors 1,528,812$3,639,0000.11%
Logos Global Management LP 220,434$525,0000.10%
Tekla Capital Management LLC 708,303$1,686,0000.07%
RA Capital Management 953,393$2,269,0000.06%
View complete list of PYXIS ONCOLOGY INC shareholders